4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-21-018310
Director sold 11,813 shares at $55.10 ($650,896)
- Director acquired 10,353 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KROLL MARK W · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-26 | Exercise or conversion : show line 1 in the form | +10,353 | $35.50 | $367,557 | 30,253 | D |
| 2021-05-26 | Sale : show line 2 in the form | −11,813 | $55.10 | $650,896 | 18,440 | D |
| Open-market sales · 11,813 sh · avg $55.10 · $650,896 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-26 | Exercise or conversion : show line 3 in the form Non-qualified Stock Option (Right to Buy) | −10,353 | 0 | D |
Loading xslF345X03/form4.xml…